OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proximity-enabled covalent binding of IL-2 to IL-2Rα selectively activates regulatory T cells and suppresses autoimmunity
Bo Zhang, Jiaqi Sun, Yeshuang Yuan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Receptor-ligand interactions for optimized endocytosis in targeted therapies
Yejin Sung, Young‐Jin Choi, Eun Sun Kim, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 524-538
Open Access | Times Cited: 2

Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies
Shan Muhammad, Tao Fan, Yang Hai, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 41

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
Yi Song, Jian Li, Yuzhang Wu
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 12

Biospecific Chemistry for Covalent Linking of Biomacromolecules
Li Cao, Lei Wang
Chemical Reviews (2024) Vol. 124, Iss. 13, pp. 8516-8549
Open Access | Times Cited: 11

A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models
Orhan Efe, Rodrigo Benedetti Gassen, Leela Morená, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 5
Open Access | Times Cited: 9

Remodeling of T-cell mitochondrial metabolism to treat autoimmune diseases
Liyan Lin, Ruyu Ren, Qiao Xiong, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 6, pp. 103583-103583
Open Access | Times Cited: 6

Protein–protein interactions: developing small-molecule inhibitors/stabilizers through covalent strategies
Bobby Lucero, Karol R. Francisco, Lawrence J. Liu, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 7, pp. 474-488
Open Access | Times Cited: 15

Pathogenesis and novel therapeutics of regulatory T cell subsets and interleukin-2 therapy in systemic lupus erythematosus
Yi‐Giien Tsai, P. F. Liao, Kai‐Hung Hsiao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13

Elevated serum IL-2 and Th17/Treg imbalance are associated with gout
Xiaoyu Zi, R. Su, Rui Su, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4

Progress in research on the role of fluoride in immune damage
Siqi Zhu, Wei Wei
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

N-terminal PEGylation Enhances Organophosphorus Hydrolase Catalysis for a Promising Fast and Long-Acting Prophylactic Candidate
Ming Ma, Yanan Zhai, Qiong‐Hua Jin, et al.
Journal of Hazardous Materials (2025) Vol. 488, pp. 137336-137336
Closed Access

Fluoride-Mediated Immune Damage Through Cytokine Network Regulation of Tregs
Bingshu Liu, Siqi Zhu, Qiong Zhang, et al.
Toxics (2025) Vol. 13, Iss. 2, pp. 95-95
Open Access

Tolerogenic nanovaccines for the treatment of type I allergic diseases
Yueping Ren, Daoke Yao, Fang Wu, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 664-685
Closed Access

Adaptive immunity and metabolism
Katherine Verbist, Piyush Sharma, Helen M. Beere, et al.
Elsevier eBooks (2025), pp. 157-190
Closed Access

Th1-related transcription factors and cytokines in systemic lupus erythematosus
Yang‐Yang Tang, Dacheng Wang, You-Yue Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10

Characterize direct protein interactions with enrichable, cleavable and latent bioreactive unnatural amino acids
Dandan Liu, Wenlong Ding, Jin-Tao Cheng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2

Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases
Luke M. Tomasovic, Kathy Liu, Derek VanDyke, et al.
BioDrugs (2023) Vol. 38, Iss. 2, pp. 227-248
Open Access | Times Cited: 6

[Research progress in systemic lupus erythematosus from 2021 to 2022].
Yongzhen Li, Xiaochuan Wu
PubMed (2023) Vol. 25, Iss. 8, pp. 785-790
Closed Access | Times Cited: 4

Chemical immunology: Recent advances in tool development and applications
Yujie Shi, Eleanor E. Bashian, Yingqin Hou, et al.
Cell chemical biology (2024) Vol. 31, Iss. 3, pp. 387-408
Open Access | Times Cited: 1

Role of regulatory T cells in mouse lung development
Jianfeng Jiang, Hongyan Lu, Mingyan Wang, et al.
Experimental Biology and Medicine (2024) Vol. 249
Open Access | Times Cited: 1

A CD25-biased interleukin-2 for autoimmune therapy engineered via a semi-synthetic organism
Jerod L. Ptacin, Lina Ma, Carolina E. Caffaro, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top